Human Wharton’s Jelly Stem Cell Secretions Inhibit Human Leukemic Cell Line K562 in vitro by Inducing Cell Cycle Arrest and Apoptosis

Emerging resistance to the tyrosine kinase inhibitors that target the BCR-ABL1 oncoprotein has prompted research for novel therapeutics against chronic myeloid leukemia (CML). Herein, we evaluated the tumor inhibitory properties of the human Wharton’s jelly stem cells (hWJSCs) co-culture (hWJSC-CC)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Cell Dev Biol
Autors principals: Huwaikem, Muneerah A. H., Kalamegam, Gauthaman, Alrefaei, Ghadeer, Ahmed, Farid, Kadam, Roaa, Qadah, Talal, Sait, Khalid H. W., Pushparaj, Peter N.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Cell and Developmental Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8044948/
https://ncbi.nlm.nih.gov/pubmed/33869169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.614988
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars